Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency

Author(s): Zohre Rezaee, Ali Yadollahpour*, Samaneh Rashidi, Pramod S. Kunwar

Journal Name: Current Drug Targets

Volume 18 , Issue 16 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Electrochemotherapy (ECT) is a combination of electroporation (EP) and chemotherapy and has been reported as a potential radiosensitizing agent for radiation therapy.

Objective: The main objective of this study was to systematically review of the literature to evaluate the effectiveness of ECT in sensitization of tumors to ionization radiation. In addition, the clinical considerations and mechanisms of action of radiosensitizing effect are discussed.

Results: Nine studies were included in this review. Bleomycin and cisplatin showed radiosensitizing effects in combined protocols with EP. EP enhances the cytotoxicity of bleomycin and cisplatin by factor of 1000 and 100, respectively. The mechanism of action of these drugs is induction of single and double strand breaks in DNA molecule. Moreover, the two main mechanisms of EP are increasing drug uptake in the tumor cells and generating reactive oxygen species. A single session ECT before radiotherapy can significantly enhance the tumor response.

Conclusion: ECT is effective for different cell lines and tumors with different levels of radiosensitivity. Our findings show that ECT can be further translated into the clinic and can be matched by singledose irradiation as well as in the fractionated regime.

Keywords: Electroporation, electrochemotherapy, cancer treatment, radiosensitizing effects, radiation therapy, tumor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 30 November, 2017
Page: [1893 - 1903]
Pages: 11
DOI: 10.2174/1389450118666170622091014
Price: $65

Article Metrics

PDF: 25
PRC: 1